IBB icon

iShares Biotechnology ETF

667 hedge funds and large institutions have $5.08B invested in iShares Biotechnology ETF in 2020 Q1 according to their latest regulatory filings, with 80 funds opening new positions, 176 increasing their positions, 253 reducing their positions, and 116 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

30% less repeat investments, than reductions

Existing positions increased: 176 | Existing positions reduced: 253

31% less first-time investments, than exits

New positions opened: 80 | Existing positions closed: 116

51% less call options, than puts

Call options by funds: $359M | Put options by funds: $729M

Holders
667
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
14
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$359M
Puts
$729M
Net Calls
Net Calls Change

Top Buyers

1 +$133M
2 +$36.3M
3 +$35.3M
4
JG
Jefferies Group
New York
+$18M
5
CB
Commerce Bank
Missouri
+$15M

Top Sellers

1 -$330M
2 -$135M
3 -$112M
4
Two Sigma Investments
Two Sigma Investments
New York
-$77.2M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$51.5M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.48B
2
$603M
3
$446M
4
$330M
5
$233M
6
$197M
7
$151M
8
$106M
9
$101M
10
$66.2M
11
$63.7M
12
$60M
13
$41.2M
14
$39.7M
15
$36.2M
16
$32.7M
17
$27.5M
18
$26.8M
19
$23.7M
20
$21.1M
21
$19M
22
$18.8M
23
$18M
24
$17.6M
25
$17.2M